https://www.selleckchem.com/products/sw-100.html
sirolimus-eluting stent; DP-ZES durable polymer zotarolimus-eluting stent; DM diabetes mellitus. Comparison of event rates of individual endpoints in patients with and without diabetes mellitus treated with PF-SES vs. DP-ZES all without statistically significant differences. Comparison of event rates of individual endpoints in overall patients with vs. without diabetes mellitus significantly different (P ≤ 0.01 for all comparisons). To investigate the role of HER2 positivity in prognosis and unresponsiveness to anti-EGFR therapy for colo
Like
Comment
Share
